Here are the S-3 shelf registrations from Tvardi Therapeutics, Inc. (TVRD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow TVRD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TVRD filings page.
Tvardi Therapeutics, Inc. is registering a shelf to offer up to $200,000,000 of common stock, preferred stock, debt securities and/or warrants.
The filing also includes a Sales Agreement prospectus authorizing offers of up to $12,500,000 of common stock under a Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC. The prospectus states the company’s common stock trades on Nasdaq under the symbol TVRD and reports a last quoted sale price of $3.15 on April 30, 2026.